Thrivent Financial for Lutherans’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.39M Sell
29,210
-14,656
-33% -$3.21M 0.01% 724
2025
Q1
$9.82M Buy
43,866
+33,243
+313% +$7.44M 0.02% 618
2024
Q4
$3.48M Sell
10,623
-8,115
-43% -$2.66M 0.01% 1094
2024
Q3
$5.63M Buy
18,738
+7,334
+64% +$2.2M 0.01% 877
2024
Q2
$3.76M Sell
11,404
-3,544
-24% -$1.17M 0.01% 1016
2024
Q1
$5.92M Sell
14,948
-57
-0.4% -$22.6K 0.01% 824
2023
Q4
$5.28M Sell
15,005
-910
-6% -$320K 0.01% 832
2023
Q3
$5.97M Buy
15,915
+2,007
+14% +$753K 0.01% 747
2023
Q2
$5.32M Buy
13,908
+10,594
+320% +$4.05M 0.01% 831
2023
Q1
$1.15M Buy
3,314
+7
+0.2% +$2.43K ﹤0.01% 1696
2022
Q4
$778K Buy
3,307
+13
+0.4% +$3.06K ﹤0.01% 1891
2022
Q3
$811K Sell
3,294
-1,557
-32% -$383K ﹤0.01% 1813
2022
Q2
$1.47M Sell
4,851
-121
-2% -$36.6K ﹤0.01% 1441
2022
Q1
$2.04M Sell
4,972
-10,247
-67% -$4.21M ﹤0.01% 1312
2021
Q4
$6.97M Buy
15,219
+10,454
+219% +$4.79M 0.01% 790
2021
Q3
$2.02M Buy
4,765
+23
+0.5% +$9.77K ﹤0.01% 1342
2021
Q2
$1.7M Sell
4,742
-1,038
-18% -$373K ﹤0.01% 1520
2021
Q1
$1.63M Sell
5,780
-38,856
-87% -$10.9M ﹤0.01% 1545
2020
Q4
$12.6M Buy
44,636
+36,364
+440% +$10.3M 0.03% 574
2020
Q3
$2.27M Sell
8,272
-186
-2% -$51.1K 0.01% 1082
2020
Q2
$1.92M Sell
8,458
-38,991
-82% -$8.86M 0.01% 1086
2020
Q1
$7.22M Sell
47,449
-23,559
-33% -$3.59M 0.03% 576
2019
Q4
$10.7M Buy
71,008
+30,736
+76% +$4.62M 0.03% 546
2019
Q3
$5.71M Sell
40,272
-79,834
-66% -$11.3M 0.02% 657
2019
Q2
$15M Sell
120,106
-42,362
-26% -$5.3M 0.05% 404
2019
Q1
$17.9M Buy
162,468
+972
+0.6% +$107K 0.06% 347
2018
Q4
$15.8M Buy
161,496
+15,857
+11% +$1.55M 0.06% 342
2018
Q3
$18M Buy
145,639
+6,037
+4% +$745K 0.06% 350
2018
Q2
$13.9M Buy
139,602
+1,582
+1% +$157K 0.05% 405
2018
Q1
$12.2M Buy
138,020
+916
+0.7% +$80.9K 0.04% 416
2017
Q4
$13.5M Sell
137,104
-114
-0.1% -$11.2K 0.05% 379
2017
Q3
$13.2M Buy
137,218
+820
+0.6% +$78.9K 0.05% 350
2017
Q2
$12.9M Buy
136,398
+1,230
+0.9% +$116K 0.05% 325
2017
Q1
$11M Buy
135,168
+1,180
+0.9% +$96.3K 0.05% 360
2016
Q4
$11.4M Sell
133,988
-44,670
-25% -$3.79M 0.05% 344
2016
Q3
$13.3M Sell
178,658
-11,080
-6% -$825K 0.06% 310
2016
Q2
$14.4M Sell
189,738
-26,760
-12% -$2.03M 0.07% 280
2016
Q1
$15M Buy
216,498
+62,490
+41% +$4.33M 0.07% 257
2015
Q4
$9.27M Buy
154,008
+96,340
+167% +$5.8M 0.04% 366
2015
Q3
$3.12M Buy
57,668
+29,668
+106% +$1.61M 0.02% 681
2015
Q2
$1.63M Buy
28,000
+1,500
+6% +$87.1K 0.01% 713
2015
Q1
$1.6M Buy
26,500
+700
+3% +$42.2K 0.01% 734
2014
Q4
$1.37M Buy
25,800
+50
+0.2% +$2.66K 0.01% 778
2014
Q3
$1.15M Sell
25,750
-100
-0.4% -$4.48K 0.01% 830
2014
Q2
$1.09M Buy
25,850
+350
+1% +$14.8K 0.01% 856
2014
Q1
$1.12M Hold
25,500
0.01% 697
2013
Q4
$1.25M Buy
25,500
+300
+1% +$14.7K 0.01% 709
2013
Q3
$1.04M Hold
25,200
0.01% 716
2013
Q2
$885 Buy
+25,200
New +$885 0.01% 729